Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$5.6 - $11.69 $532,000 - $1.11 Million
-95,000 Reduced 54.29%
80,000 $474,000
Q1 2024

May 14, 2024

BUY
$5.05 - $10.0 $883,750 - $1.75 Million
175,000 New
175,000 $1.59 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $201M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Resolute Capital Asset Partners LLC Portfolio

Follow Resolute Capital Asset Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Capital Asset Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Capital Asset Partners LLC with notifications on news.